What is the Share Price of Fredun Pharmaceuticals Ltd?

Fredun Pharmaceuticals Ltd share price is ₹680.00 As on 09 May, 2025|10:27

Home
>
Stocks
>
Fredun Pharmaceuticals Ltd

Fredun Pharmaceuticals Ltd Share Price

Q: What is the Market Cap of Fredun Pharmaceuticals Ltd?

The Market Cap of Fredun Pharmaceuticals Ltd is ₹329 As on 09 May, 2025|10:27

Q: What is PE Ratio of Fredun Pharmaceuticals Ltd?

The P/E ratio of Fredun Pharmaceuticals Ltd is 17.5 As on 09 May, 2025|10:27

Q: What is PB Ratio of Fredun Pharmaceuticals Ltd?

The PB ratio of Fredun Pharmaceuticals Ltd is 2.45 As on 09 May, 2025|10:27

₹ 0.00 0 (0%)
Updated on 01-01-1970 5:30 AM

Stock Rating

BSE

Pros 1

Cons 9

Fredun Pharmaceuticals Ltd Price Performance

Day's Low
₹0

Day's High
₹0

₹ 0

52-w low
₹0

52-w high
₹0

Day's open
₹0
Previous close
₹0
VWAP
₹0
Lower price band
₹0
Upper price band
₹0

Today's Market Action

Its last traded stock price on BSE was 680.00 down by -2.48%. The total volume of shares on NSE and BSE combined was 288 shares. Its total combined turnover was Rs 0.02 crores.

Fredun Pharmaceuticals Ltd Medium and Long Term Market Action

The stock price of Fredun Pharmaceuticals Ltd is down by -100% over the last one month. Don't forget to check the full stock price history in the table below.

Fredun Pharmaceuticals Ltd Fundamentals

Market Cap (Cr): 329
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Fredun Pharmaceuticals Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Fredun Pharmaceuticals Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Fredun Pharmaceuticals Ltd

Data not available.

Fredun Pharmaceuticals Ltd FAQ's

What is Share Price of Fredun Pharmaceuticals Ltd?

What is the Market Cap of Fredun Pharmaceuticals Ltd?

What is PE Ratio of Fredun Pharmaceuticals Ltd?

What is PB Ratio of Fredun Pharmaceuticals Ltd?

What is the CAGR of Fredun Pharmaceuticals Ltd?

How to Buy Fredun Pharmaceuticals Ltd Share?

Can I buy Fredun Pharmaceuticals Ltd from Samco?

How do I buy Fredun Pharmaceuticals Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Asset Light Business
The company operates a great asset light business with a high Asset turnover ratio of 6.48. A high asset turnover ratio is a great driver of RoE and can improve shareholder returns. A relatively higher asset turnover ratio also will result in lower dilution as the business grows its revenues as earnings.

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Poor Cash Flow Conversion
The business has very poor cash conversion ratio of only 0.00% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
Low Interest Coverage
The company has a very low Interest coverage ratio of 2.71 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
Poor Capital Allocation
The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 86.20 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 346 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
Poor Corporate Governance
The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(09/05/2025)

Margin of Safety Index: High

0% People are bullish about Fredun Pharmaceuticals Ltd

0 % People are bearish about Fredun Pharmaceuticals Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %